Advaxis (ADXS) finalist for 4 VIE Awards and Preliminary Data Showing Complete Response and No Recurrences to Date in All Treated Patients. Still flying under the radar with all their potential.

Preliminary Data From a Phase 1/2 Trial of ADXS-HPV in HPV-Associated Anal Cancer in Combination With Chemo-radiation Showing Complete Response and No Recurrences to Date in All Treated Patients

Submitted March 16, 2015 at 12:00PM by WeightLiftingLulu http://ift.tt/1CpFTkP